Acadia Healthcare (NASDAQ:ACHC) reported Q2 EPS of $0.88, $0.10 better than the analyst estimate of $0.78. Revenue for the quarter came in at $651.7 million versus the consensus estimate of $650.82 million.
GUIDANCE:
Acadia Healthcare sees FY2022 EPS of $2.93-$3.18, versus the consensus of $3.01. Acadia Healthcare sees FY2022 revenue of $2.56-2.6 billion, versus the consensus of $2.59 billion.